AQP4 and glioblastoma: All these suggest that the AQP4ex isoform is critical in the triggering event of progressive downregulation and mislocalization of AQP4 in GBM, which may affect the integrity of the BBB, indicating that AQP4ex could be a potential early biomarker of GBM progression.